$4450
$3560
The donor blood components market size is projected to reach US$ 14.64 billion by 2031 from US$ 10.08 billion in 2024. The market is expected to register a CAGR of 5.7% during 2025–2031. The rising demand for plasma-derived therapies is likely to bring in new market trends during the forecast period.
Donor Blood Components Market Analysis
The donor blood components market is one of the prominent segments of the healthcare industry, driven by the increasing need for safe transfusions during surgery, trauma, cancer treatment, and chronic disease. Donor blood components include red blood cells (RBCs), plasma, platelets, and cryoprecipitate. The donor blood components market growth is being propelled by rising global awareness, aging populations, and growing advancements in collection and storage technologies. However, issues such as low rates of voluntary donations in certain regions, regulatory issues, and logistical limitations remain. New technologies such as apheresis and pathogen reduction systems are improving product safety and efficiency. Furthermore, government and NGO initiatives to increase regular, voluntary blood donation are increasing the donor base. The market has great potential, particularly in evolving healthcare systems.
Donor Blood Components Market Overview
The donor blood components market is rapidly expanding due to the rising prevalence of cancer and immunosuppressive diseases, and increasing donor awareness. Prominent players operating in the market are focusing on innovations and collaborative efforts for enhanced product availability and reach. However, the inconsistent voluntary donations hinder market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Donor Blood Components Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Donor Blood Components Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Donor Blood Components Market Drivers and Opportunities
Rising Prevalence of Cancer and Immunosuppressive Diseases Fuel Market Growth
The incidence of cancer and immunosuppressive disorders is increasing across the globe. Cancer patients frequently demand RBCs and platelet transfusions due to the adverse effects of chemotherapy, radiation, and bone marrow transplantation, which lead to anaemia and thrombocytopenia. As per the American Cancer Society, in the US, ~2 million new cancer cases were diagnoses in 2024, where estimated numbers of lymphoma were 89,190, Myeloma were 35,780, and Leukemia were 62,770. Most patients rely significantly on transfusions of blood components to cope with side effects and enhance quality of life.
Patients with immunosuppressed diseases such as HIV/AIDS, autoimmune diseases, and those on immunosuppressive therapy following organ transplantation need plasma-derived products such as immunoglobulins and clotting factors in order to enhance immune function and avert infections. In 2023, the Joint United Nations Programme on HIV/AIDS (UNAIDS) reported that more than 39.9 million individuals were living with HIV worldwide, with many relying on blood components for survival.
According to GLOBOCAN estimates, the worldwide cancer prevalence is estimated to account for more than 28.4 million new cases per year by 2040, which will significantly boost demand for blood components in oncology treatment centers and hospitals. Furthermore, the rising population of older persons, who are more prone to cancer and immunosuppressive illnesses, drives demand for a secure and trustworthy blood supply.
These increasing health conditions highlight the paramount need for the constant provision of blood donation and high-tech blood component processing technologies. Healthcare institutions and blood banks are expanding their capability to keep up with this demand. Therefore, the increasing prevalence of cancer and immunosuppressive disorders boosts the donor blood component market growth.
Emerging Market Demand to Create Lucrative Opportunities in the Market
Emerging economies, particularly in Southeast Asia, Latin America, and some regions in Africa, offer a strong growth opportunity for the donor blood component market. As healthcare infrastructure in these economies grows, investment in blood donation facilities is emerging as a strategic imperative. In Argentina, Brazil, and Mexico, voluntary donations voluntary donation programs have gained significant traction: Latin America received more than 9.2 million units in 2023, a 15.5% increase over 2020, with 56.8% of donations voluntary due to mobile drives and online campaigns. This growth represents the collaborative coordination of awareness campaigns and public–private alliances that have had on national blood systems. Similarly, in Indonesia, for instance, corporate donors such as Asian Agri initiated regional Blood Donation Weeks, accumulating hundreds of units from rural provinces. In June 2024, they engaged 414 donors and collected 287 units from three provinces, contributing to inventory and awareness. These private-sector cooperation enhances community trust and donor participation.
According to the WHO, the demand for blood products is projected to increase 5% each year in developing nations. To respond to the demand, the nations are focusing on the modernization of infrastructure, such as Indonesia's new plasma-fractionation factory and increased mobile blood collections in Africa. Technological utilization in the form of apheresis equipment, NAT testing, and automation processing is enhancing safety and public trust.
The convergence of growing medical demand, increasing voluntary donation, digital outreach, and regulatory reforms positions emerging markets for growth in donor blood services. Developments in these systems not only meet increasing clinical need but also catalyze long-term sustainability in the global donor blood component market.
Donor Blood Components Market Report Segmentation Analysis
Key segments that contributed to the derivation of the donor blood components market analysis are blood component, indication, application, age group, and end user.
- Based on blood component, the donor blood components market is segmented into red blood cells, white blood cells, platelets, plasma, and others. The red blood cells segment held the largest share of the market in 2024.
- By indication, the donor blood components market is bifurcated into immunosuppression and oncology. The immunosuppression segment dominated the market in 2024.
- In terms of application, the donor blood components market is segmented into anemia management, thrombocytopenia treatment, coagulopathy correction, supportive care during chemotherapy, surgery, and others. The anemia management segment held the largest share of the market in 2024.
- By age group, the donor blood components market is bifurcated into adult and child. The adult segment dominated the market in 2024.
- As per end user, the donor blood components market is categorized into hospitals, oncology centers, transplant centers, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2024.
Donor Blood Components Market Share Analysis by Geography
The geographic scope of the donor blood components market report mainly focuses on five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the market in 2024. It is expected to continue its dominance in the global market during the forecast period. The US is the largest market for donor blood components in the world. According to the American Cancer Society, in 2022, ~1.9 million new cases of cancer were diagnosed in the country, and it caused ~0.61 million deaths. Cancer patients require regular blood transfusions during chemotherapy treatment. Chemotherapy and radiation therapies often lead to severe thrombocytopenia and neutropenia, necessitating platelet and plasma transfusions to prevent life-threatening bleeding and infections. According to The Leukemia & Lymphoma Society Facts and Statistics Overview, one person in the US is diagnosed with leukemia, lymphoma, or myeloma every 3 minutes. Also, ~456,481 people are living with leukemia. Leukemia affects bone marrow, reducing healthy blood cell production and causing anemia, which makes frequent transfusions of red cells, platelets, and plasma essential.
To meet the growing demand for blood components, blood banks and organizations, such as the American National Red Cross and the Association for the Advancement of Blood & Biotherapies, have intensified donor recruitment and blood collection efforts. As per the American National Red Cross, every two seconds, someone in the country needs blood or platelets for surgeries, cancer treatment, chronic illnesses, and traumatic injuries. ~29,000 units of RBCs, 5,000 units of platelets, and 6.500 units of plasma are needed every day in the nation. Per the same source, an estimated 6.8 million people donate blood each year in the US. This donation adds up to ~13.6 million units of whole blood and RBCs collected annually in the country. The American National Red Cross provides ~40% of the nation’s blood and blood cell components to donors, and ~16 million blood components are transfused annually in the US.
Furthermore, increasing demand for organ transplantation is likely to propel the demand for blood components. As per the data from the Organ Procurement and Transplantation Network (OPTN), the number of transplants performed in the country increased from 41,000 in 2021 to 48,149 in 2024. On average, the nation performed 132 transplants a day in 2024. During transplant surgeries, patients often experience substantial blood loss, requiring large quantities of blood to maintain stable circulation and support organ function. Recipients may need blood transfusions before and after surgery to manage anemia, boost recovery, and counter immune suppression therapies that can affect blood cell production.
Donor Blood Components Market Report Scope
Donor Blood Components Market News and Recent Developments
The donor blood components market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. Key developments witnessed in the donor blood components market are as follows:
- Red Cross and Armed Services Blood Program launch partnership to strengthen military and civilian blood supply. (Source: The American National Red Cross, Company News, July 2025)
- NHS calls for 200,000 new blood donors as supplies run low. (Source: NHS Blood and Transplant (NHSBT), Press Release, XX 2024)
Donor Blood Components Market Report Coverage and Deliverables
The "Donor Blood Components Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Donor blood components market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Donor blood components market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Donor blood components market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the donor blood components market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The rising prevalence of cancer and immunosuppressive diseases and increasing donor awareness are among the significant factors fueling the market growth.
North America dominated the market in 2024.
The rising demand for plasma-derived therapies is likely to emerge as a new growth trend in the market in the coming years.
Roswell Park Comprehensive Cancer Center, Policlinico of Milan, Vitalant, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, Tata Memorial Hospital, Memorial Sloan Kettering Cancer Center are among the key players operating in the market.
The market is expected to register a CAGR of 5.7% during 2025–2031.
The market value is expected to reach US$ 14.64 billion by 2031.
The List of Companies - Donor Blood Components Market
- Mayo Clinic
- Cleveland Clinic
- Johns Hopkins Medicine
- Memorial Sloan Kettering Cancer Center
- Singapore General Hospital
- King’s College Hospital
- Charité University Hospital
- Royal Melbourne Hospital
- St. Michael’s Hospital
- Tokyo Medical University Hospital
- Massachusetts General Hospital
- UCLA Medical Center
- NewYork-Presbyterian Hospital
- Karolinska University Hospital
- The Royal Free Hospital
- Zentrum für Transfusionsmedizin (ZTM)
- Asan Medical Center
- Apollo Hospitals
- Cecil Memorial Hospital
- King Fahd Military Medical Complex
- Bumrungrad International Hospital
- Hospital das Clínicas
- Aga Khan University Hospital
- University of California, San Francisco (UCSF) Medical Center
- Peking Union Medical College Hospital
- The Aga Khan University Hospital (Nairobi)
- Fuda Cancer Hospital
- St. Thomas' Hospital
- Beijing Tiantan Hospital
- Cairo University Hospital
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Donor Blood Components Market
Jul 2025
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Jul 2025
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Jul 2025
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage:Â Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Jul 2025
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2025
Prescription Drugs Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2025
Regenerative Dentistry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Natural and Synthetic), Technology (Tissue Engineering, Stem Cell Therapy, and Others), Application (Periodontal Regeneration, Endodontic Regeneration, Tooth Reconstruction, Bone Regeneration, and Others), Age Group (Adult and Pediatric), End User (Dental Clinics, Hospital, and Others), and Geography
Jul 2025
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Jul 2025
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography